Human beta cells can be easily induced to replicate

Jan 13, 2009

Researchers at the University of Pittsburgh School of Medicine have successfully induced human insulin-producing cells, known as beta cells, to replicate robustly in a living animal, as well as in the lab. The discovery not only could improve models and methods for studying diabetes, but also opens up new possibilities for treating the condition.

"Most scientists thought that these important pancreatic cells could not be induced to regenerate, or could only replicate very slowly," explained senior author Andrew F. Stewart, M.D., professor of medicine and chief of the Division of Endocrinology and Metabolism at the University of Pittsburgh School of Medicine. "This work provides proof-of-principle that the production of human beta cells can be stimulated, and that the newly generated cells function effectively both in the lab and in a living animal."

The findings are in the early online version of Diabetes, one of the journals of the American Diabetes Association.

Lead authors Nathalie Fiaschi-Taesch, Ph.D., assistant professor in Pitt's endocrinology division, and Todd A. Bigatel, M.D., a graduate of the postdoctoral fellowship program, identified molecules that play key roles in human beta, or islet, cell replication, building on previous work conducted by co-author Irene Cozar-Castellano, Ph.D., also an instructor of endocrinology, who performed similar studies using mouse cells.

They found that, unlike rodents, human beta cells contain a significant amount of a protein called cdk-6. When cdk-6 production was increased using a viral vector carrying the cdk-6 gene, the cells replicated. Stimulation was further enhanced by increasing production of another cell cycle molecule called cyclin D1. Untreated human islets did not replicate.

"After we transplanted some of these engineered human beta cells under the outer layer of a kidney in a diabetic mouse, we saw that replication continued and blood sugar levels normalized," explained Dr. Fiaschi-Taesch. "When we took out the kidney that contained the insulin-producing cells, the mouse immediately developed diabetes again."

The prospect of being able to study human beta cells and their replication in vivo, meaning in a living animal, could greatly improve diabetes study models, and could lead to techniques to generate new beta cells in patients with diabetes. In the future, it also could allow more effective therapeutic transplants of insulin-producing cells - either by expanding the numbers of cells available from a single cadaveric donor or from a gene-enhanced version of the patient's own cells, or by establishing permanent cell lines from existing beta cells or stem cells, Dr. Stewart pointed out.

He added that cell cycle replication molecules might also be targets for drugs that could transiently turn on beta cell replication to increase insulin production.

Source: University of Pittsburgh

Explore further: Test shows Spain nursing assistant clear of Ebola

add to favorites email to friend print save as pdf

Related Stories

Battling superbugs with gene-editing system

Sep 21, 2014

In recent years, new strains of bacteria have emerged that resist even the most powerful antibiotics. Each year, these superbugs, including drug-resistant forms of tuberculosis and staphylococcus, infect ...

Some anti-inflammatory drugs affect more than their targets

Aug 21, 2014

Researchers have discovered that three commonly used nonsteroidal anti-inflammatory drugs, or NSAIDs, alter the activity of enzymes within cell membranes. Their finding suggests that, if taken at higher-than-approved ...

Recommended for you

Test shows Spain nursing assistant clear of Ebola

7 hours ago

A Spanish nursing assistant appears to have recovered from the Ebola virus, authorities said Sunday, nearly two weeks after she became the first person infected outside West Africa in the current outbreak.

Nigeria expected to be declared Ebola-free

18 hours ago

Nigeria is expected to be declared Ebola-free on Monday, just three months after fears that the virus could spread like wildfire through Africa's most populous nation.

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

NeilFarbstein
not rated yet Jan 13, 2009
The experiments above can be used to base for an ex vivo treatment of diabetes.
Conatct me at the e-mail address belwo to discuss a novel ex vivo gene therapy.
Neil Farbstein
President
Vulvox Inc.
protn7@att.net
E_L_Earnhardt
not rated yet Jan 13, 2009
WARM the cells and and the "growth rate" accelerates!